E
Eduard F. Stange
Researcher at Robert Bosch Hospital
Publications - 248
Citations - 22978
Eduard F. Stange is an academic researcher from Robert Bosch Hospital. The author has contributed to research in topics: Inflammatory bowel disease & Crohn's disease. The author has an hindex of 63, co-authored 238 publications receiving 21585 citations. Previous affiliations of Eduard F. Stange include Bosch & University of Tübingen.
Papers
More filters
Journal ArticleDOI
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
Axel Dignass,G. Van Assche,James O. Lindsay,Marc Lémann,Johan D. Söderholm,Jean-Frederic Colombel,Silvio Danese,André D'Hoore,Miquel A. Gassull,Fernando Gomollón,Daan W. Hommes,Pierre Michetti,Colm O'Morain,Tom Øresland,Alastair Windsor,Eduard F. Stange,Simon Travis +16 more
TL;DR: This paper is the second in a series of three publications relating to the European evidence-based consensus on the diagnosis and management of Crohn's disease and concerns the management of active disease, maintenance of medically induced remission and surgery.
Journal ArticleDOI
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis
Gert Van Assche,Axel Dignass,Julián Panés,Laurent Beaugerie,John A. Karagiannis,Mathieu Allez,Thomas Ochsenkühn,Timothy R. Orchard,Gerhard Rogler,Edouard Louis,Limas Kupčinskas,Gerassimos J. Mantzaris,Simon Travis,Eduard F. Stange +13 more
TL;DR: The aim of the Consensus is to promote a European perspective on the management of Crohn's disease and its dilemmas to avoid duplication of effort in the future.
Journal ArticleDOI
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
Axel Dignass,James O. Lindsay,Andreas Sturm,Alastair Windsor,Jean-Frederic Colombel,Mathieu Allez,G. D'Haens,André D'Hoore,Gerassimos J. Mantzaris,Gottfried Novacek,Tom Øresland,Walter Reinisch,Miquel Sans,Eduard F. Stange,Severine Vermeire,Simon Travis,Gert Van Assche +16 more
TL;DR: The most widely used index for severe UC remains that of Truelove and Witts3: any patient who has a bloody stool frequency ≥ 6/day and a tachycardia (> 90 bpm), or temperature > 37.8 °C, or anaemia (haemoglobin 30 mm/h) has severe ulcerative colitis (Table 1.3) as mentioned in this paper.
Second European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Current management
Axel Dignass,James O. Lindsay,Andreas Sturm,Alastair Windsor,Jean-Frédéric Colombel,Mathieu Allez,G. D'Haens,André D'Hoore,Gerassimos J. Mantzaris,Gottfried Novacek,Tom Øresland,W. Reinisch,Miquel Sans,Eduard F. Stange,Severine Vermeire,Simon Travis,Gert A. Van Assche +16 more
TL;DR: In this article, the authors presented a study of Gastroenterology at the University of Toronto and University of Leuven (Belgium) with the aim of identifying the cause of colorectal cancer.
Journal ArticleDOI
Reduced Paneth cell α-defensins in ileal Crohn's disease
Jan Wehkamp,Nita H. Salzman,Edith Porter,Edith Porter,Sabine Nuding,Michael Weichenthal,Robert E. Petras,Bo Shen,Elke Schaeffeler,Matthias Schwab,Rose Linzmeier,Ryan W. Feathers,Hiutung Chu,Heriberto Lima,Klaus Fellermann,Tomas Ganz,Eduard F. Stange,Charles L. Bevins +17 more
TL;DR: It is reported that patients with CD of the ileum have reduced antibacterial activity in their intestinal mucosal extracts, and changes in HD5 expression levels, comparable to those observed in CD, had a pronounced impact on the luminal microbiota.